MTOR and colorectal carcinoma: On the one hand, previous articles have reported that alterations in the PI3K pathway are universal in CRC, wherein activation of the PI3K pathway could contribute to the malignant transformation of benign lesions [40], and the overexpression of PI3K/Akt/mTOR signal transduction could exacerbate the progression of CRC [41].